Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 25, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2027

Conditions

X-linked Retinoschisis

Interventions

DRUG

ZM-01-L

rAAV-hRS1 intravitreal injection of low dose

DRUG

ZM-01-H

rAAV-hRS1 intravitreal injection of high dose

Trial Locations (1)

RECRUITING

Wuhan University Renmin Hospital affiliated with Hanchuan Hospital, Xiaogan